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O’Connora, Massimo Napolitanoa. aHackensack University Medical
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Objectives: To evaluate early outcomes and short-term durability of
thoracic stent cuffs in patients with abdominal aortic aneurysms (AAA)
and infrarenal necks too large for standard endovascular aneurysm repair
(EVAR) who were symptomatic, not suitable for open surgery, and could
not wait for a custom fenestrated device to be created.
Methods: From July 2010 to December 2012, 13 patients with juxta-
or pararenal AAA underwent endovascular repair with thoracic aortic
endografts as proximal aortic cuffs in conjunction with standard EVAR
devices. The patients were symptomatic and were deemed unﬁt for open
surgery due to severe cardiopulmonary and/or renal comorbidities. All
patients had infrarenal neck diameters greater than the indications for use
for standard aortic endografts. Primary end points were technical success
(as deﬁned by aneurysm exclusion without endoleak), follow-up aneurysm
exclusion by computed tomographic angiogram, and 30-day and long-
term mortality.
Results: Thirteen patients (10 men, 3 women) with a mean age of
77.1 years underwent EVAR who presented with symptomatic juxta- or
pararenal abdominal aortic aneurysms. The mean aneurysm size was 7.2
cm, and the mean infrarenal aortic neck diameter was 35.5 mm
measured by centerline analysis. Technical success was achieved in
100% of cases. The 30-day mortality was 8% (one of 13 patients). At
a mean follow-up of 524 days, there have been no endoleaks or other
aneurysm related mortalities. There was one death due to stroke at
605 days postop.
Conclusions: Complex endovascular repair of juxta and pararenal
AAA using thoracic stents cuffs can be safely and successfully performed
in symptomatic patients medically unﬁt for open repair. Using thoracic stent
cuffs below the visceral vessels may reduce the complexity and possibly the
risk of repair when compared with fenestrated endografts. These techniques
can be used for urgent and emergent cases where the wait time for fenes-
trated technology is prohibitive. Although our results have demonstrated
short-term success, long-term durability of this technique with further eval-
uation is required.
Clinical Impact of Isolated Infrarenal Aortic Stenosis
Rafael D. Malgora, Nicos Labropoulosa, Marc Borgeb, Celso Diasc, Peter
Pappasd, Apostolos Tassiopoulosa. aStony Brook University Medical
Center, Stony Brook, NY; bLoyola University Medical Center, Chicago,
Ill; cThe Aroostok Medical Center, St. Presque Isle, Me; dThe Brooklyn
Hospital Center, New York, NY
Objectives: To evaluate the clinical characteristics and treatment
outcomes in patients with isolated infrarenal aortic stenosis
Methods: Consecutive patients with isolated infrarenal aortic
stenosis who presented with claudication or lower extremity distal
embolization were included. Patients with concomitant disease in the
iliac and lower extremity arteries and those with less than 2-year
follow-up were excluded. Clinical presentation, risk factors, and endo-
vascular treatment were recorded. Clinical evaluation, duplex ultra-
sound, and ankle-brachial index were performed at 1, 6, 12 months,
and annually thereafter.
Results: There were 51 patients with aortic stenosis of whom 34
did not fulﬁll the inclusion criteria leaving 17 for analysis. These wereTable. Patency rates, limb salvage, survival, and amputation-free survival in AA
PP 12/36 months SP 12/36 months
AA(n ¼ 108) 77 6 4%/70 6 5% 90 6 1%/84 6 2%
CAU (n ¼ 730) 78 6 2%/68 6 2% 90 6 3%/84 6 4%
P .845 .736
AA endo (n ¼ 97) 78 6 5%/71 6 6% 89 6 4%/84 6 5%
CAU endo (n ¼ 696) 80 6 2%/66 6 2% 89 6 1%/84 6 2%
P .427 .775
AA open (n ¼ 31) 75 6 8%/68 6 10% 90 6 6%/83 6 8%
CAU open (n ¼ 196) 80 6 3%/69 6 4% 87 6 3%/80 6 4%
P .450 .748all females, mean age 44 years, range 37-49. All but one patient had
three or more risk factors. Fifteen patients had claudication and seven
presented with distal embolization. The lesion length was 4 cm in two
patients. Seven patients underwent transluminal balloon angioplasty,
ﬁve had angioplasty followed by stenting, and ﬁve had primary stenting.
Procedural complications developed in three patients at the access site.
After intervention, the pressure gradient across the stenotic area was
signiﬁcantly improved in all patients (49 6 11.6 mm Hg vs 6.3 6 2
mm Hg; P < .001). Postoperative ankle-brachial index was improved
in all patients (mean preoperative 0.66 6 0.07 vs postoperative 0.92
6 0.06; P < .001). The mean follow-up was 3.7 years, range 2-7.
Two patients required reintervention with balloon angioplasty at 4 and
5 years and a third one angioplasty plus stenting at 3 years. None of
the 17 patients developed life style limiting claudication or distal
embolization.
Conclusions: Symptomatic isolated infrarenal aortic stenosis is rare
but may be found in young females who have at least three cardiovascular
risk factors present. Balloon angioplasty alone or angioplasty plus stenting
are effective treatments with high success and low complication rates in
this cohort of patients
Similar Outcomes in African American Compared with Caucasian Men
with Chronic Limb Ischemia in an Equal Access to Care Setting
Hasan H. Dosluoglua, Raphael Blochleb, Linda M. Harrisb, Maciej L.
Dryjskib. aVA Western NY Healthcare System, SUNY at Buffalo, Buffalo,
NY; bSUNY at Buffalo, Buffalo, NY
Objectives: African Americans (AA) with symptomatic peripheral
arterial disease (PAD) have been reported to have less revascularization
attempts and poorer patency and limb salvage rates. The goal of this study
is compare the outcomes in AA and Caucasian (CAU) men with chronic
limb ischemia in a setting with equal access to care.
Methods: All AA and CAU men who were treated for symptomatic
PAD between November 2003 and June 2012 were included.
Results: Of the 838 men (1072 limbs), 108 were AA (139
limbs) and 730 were CAU (933 limbs). AA were more likely to
have insulin dependent diabetes mellitus (IDDM), hypertension, dial-
ysis-dependence, lower albumin levels, and critical limb ischemia
(CLI) (73% vs 61%, P ¼ .006) whereas CAU had more coronary
artery disease, dyslipidemia, chronic obstructive pulmonary disease,
and were older. Type of revascularization, and primary amputation
rates (9% vs 7%; P ¼ .4) were similar between groups. Infrapopliteal
interventions were more frequent in AA (47% vs 28%; P < .001).
Perioperative morbidity and mortality were similar. Patency rates,
limb salvage, and survival were similar in AA and CAU who under-
went open, or endovascular revascularization (mean follow-up, 31.5
months) (Table). IDDM, gangrene, poor functional capacity, and
dialysis-dependence independently predicted limb loss in multivariate
analysis, whereas race did not.
Conclusions: In an equal access to care setting, similar outcomes can
be achieved in AA men with symptomatic PAD, despite poorer functional
status, higher rates of dialysis-dependence, IDDM, and more frequent infra-
popliteal interventions.
Is Intramural Thrombus Protective and/or Predictive of Type II
Endoleak in Patients Undergoing EVAR?
Sam Tyagi, Shinichi Fukuhara, Stephen Haveson. Beth Israel Medical
Center, New York, NYand CAU groups
LS 12/36 months Survival 12/36 months AFS
84 6 4%/79 6 5% 80 6 3%/67 6 4% 66 6 5%/56 6 5%
90 6 1%/86 6 2% 80 6 1%/64 6 2% 66 6 2%/46 6 2%
.078 .865 .412
84 6 5%/77 6 6% 79 6 4%/65 6 5% 62 6 6%/51 6 6%
90 6 2%/86 6 2% 82 6 2%/64 6 2% 66 6 2%/45 6 3%
.066 .561 .660
84 6 9%/84 6 9% 87 6 6%/80 6 9% 79 6 9%/69 6 12%
92 6 3%/85 6 4% 81 6 3%/70 6 4% 68 6 4%/52 6 5%
.705 .504 .269
